In a study using rodent models, propolis resulted in reduced hypertension. 

Santa Clara University

Propolis has helped function as a treatment for various comorbidities associated with high-risk of mortality from COVID-19: hypertension, diabetes, cancer and multiple respiratory diseases. 

Propolis is an effective adjuvant therapy for multiple COVID-19 patient comorbidities

Berretta, A. A., Silveira, M., Cóndor Capcha, J. M., & De Jong, D. (2020). Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 131, 110622. Advance online publication. https://doi.org/10.1016/j.biopha.2020.110622

Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19

- Propolis has demonstrated to be effective in reducing the harmful effects of bladder, blood, brain, liver, kidney, head and neck, prostate, pancreas, breast and skin cancers. 
- In vivo and in vitro studies have demonstrate how extracts of propolis have the ability to prevent tumor cell growth and inhibit angiogenesis. 

How Propolis can help COVID-19 Patients with Cancer

Evidence for the Potential of Propolis to Help COVID-19 Patients with Hypertension 

In rats with diabetes, propolis was found to reduce glycemia and insulin resistance, as well as reduce levels of glucose and lipids in the blood, and reduce free radicals. 


Learn Before

Related